[EN] NOVEL SUBSTITUTED QUINOLINE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS [FR] NOUVEAUX COMPOSÉS QUINOLÉINE SUBSTITUÉS EN TANT QU'INHIBITEURS DE S-NITROSOGLUTATHIONE RÉDUCTASE
[EN] NOVEL SUBSTITUTED QUINOLINE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS [FR] NOUVEAUX COMPOSÉS QUINOLÉINE SUBSTITUÉS EN TANT QU'INHIBITEURS DE S-NITROSOGLUTATHIONE RÉDUCTASE
[EN] COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS<br/>[FR] COMPOSÉS EN TANT QU'INHIBITEURS DE LA S-NITROSOGLUTATHION RÉDUCTASE
申请人:N30 PHARMACEUTICALS LLC
公开号:WO2012170371A1
公开(公告)日:2012-12-13
The present invention is directed to compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.
Novel Substituted Quinoline Compounds as S-Nitrosoglutathione Reductase Inhibitors
申请人:Sun Xicheng
公开号:US20130178499A1
公开(公告)日:2013-07-11
The present invention is directed to novel quinoline compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.